SUMMARY Using specific histamine HI and H2 receptor antagonists, evidence is presented for the existence of both H1 and H2 receptors on human articular chondrocytes in vitro. Stimulation of the H1 receptor by histamine (range 0-18 to 17-8 imol/l) significantly increased prostaglandin E (PGE) production, while activation of the histamine H2 receptor increased intracellular cyclic adenosine-5'-monophosphate (AMP). The histamine H1 antagonists mepyramine and tripelennamine blocked the histamine induced increase in PGE production, and the H2 antagonists cimetidine and ranitidine prevented the increase in intracellular cyclic AMP. These observations suggest that mast cell-chondrocyte interactions mediated via histamine may contribute to some of the pathophysiological changes observed in joint disease.
After our observation of mast cells at sites of cartilage erosion in rheumatoid knee joints' we have examined the potential of mast cell components to affect chondrocyte metabolism. The addition of whole mast cell products, prepared from purified rat or dog mast cells, caused a marked increase in the intracellular cyclic AMP levels of cultured chondrocytes, an observation subsequently explained by the demonstration of histamine H2 receptors on chondrocytes derived from human, canine, and fetal bovine articular cartilage.2 As with histamine H2 receptors found in gastric mucosa, rat uterus, and guinea pig heart,3 stimulation by histamine activated adenylate cyclase and produced an increase in intracellular cyclic AMP. Alterations in intracellular cyclic AMP levels have been shown to affect a number of cellular processes, including prostaglandin (PG) production by human adipose tissue.5
Since increased PG production is a common feature of inflammatory joint disease we have investigated the effect of histamine on PGE production by chondrocytes. We report here that histamine was found to increase PGE production by human articular chondrocytes, but surprisingly this process was shown to be mediated not by a histamine H2 receptor but by a type 1 receptor. (Tables 1 and 2 ).
Materials and methods

Materials
The H1 antagonists chlorpheniramine, mepyramine, and tripelennamine each caused a dose related inhibition of the histamine stimulated PGE production at concentrations below 10-6 mol/l (Fig.  1) 
